FGF21 and metabolic dysfunction-associated steatotic liver disease: In this study, we aimed to delineate the critical role of FGF21 signaling in the ameliorative effects of KD on hepatic steatosis in order to offer new insights into the potential of KD in the treatment of NAFLD.